17 January 2022 - Deborah Wilkes
Premium
GlaxoSmithKline (GSK) has rejected three Unilever takeover offers for its Consumer Healthcare business, including one worth GBP50 billion (USD68 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.